No Data
No Data
Earnings Preview: Senseonics to Report Financial Results Post-market on November 07
Senseonics Holdings Expands Equity and Financial Strategy
Express News | Senseonics Holdings Inc - to Issue Warrants for 45.7 Mln Shares at $0.35 Each
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
Express News | Senseonics Holdings Inc Files for Common Stock Offering of up to $55 Mln - SEC Filing
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
萬軍無兵策天鳳 : Without the start of sales and good sales data, it feels difficult to drive the stock price.
Trytosaveabit OP 萬軍無兵策天鳳 : Agreed! Hehehe! I do hate when companies release what could be great news and don’t put the important parts! Like a contract! But not how much it’s worth? Hehehe GL
一哭二闹三上悠亚 萬軍無兵策天鳳 : Since 2020, the current stocks are still down by 70%, so new investors should not hold large positions. After FDA approval in 90 days, there was a sharp drop on the same day, followed by a sustained decline for six months. Recently, after FDA approval in 365 days, the stocks dropped back to near the lowest point within two days. Every financial report results in explosions, CEOs frequently sell stocks, split shares, and issue new shares that are not beneficial to shareholders. Moreover, the company's products are all prescription drugs with limited sales channels and the company is heavily indebted, so it would not be surprising if it goes bankrupt one day.